Provided by Tiger Trade Technology Pte. Ltd.

Vertex, Inc.

13.83
-0.3300-2.33%
Post-market: 13.830.00000.00%19:30 EDT
Volume:1.42M
Turnover:19.70M
Market Cap:2.24B
PE:627.55
High:14.27
Open:14.12
Low:13.76
Close:14.16
52wk High:26.54
52wk Low:10.21
Shares:162.00M
Float Shares:70.89M
Volume Ratio:1.18
T/O Rate:2.00%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.0220
EPS(LYR):0.0444
ROE:1.46%
ROA:0.65%
PB:9.29
PE(LYR):311.51

Loading ...

Vertex Pharmaceuticals added to ‘US 1 List’ at BofA

TIPRANKS
·
Aug 11

Vertex Pharmaceuticals Inc. Stock Rises 5.6%, Outperforms Peers

Dow Jones
·
Aug 11

Analysts Offer Insights on Healthcare Companies: Jade Biosciences (JBIO), Silence Therapeutics (SLN) and Vertex Pharmaceuticals (VRTX)

TIPRANKS
·
Aug 11

Vertex Pharmaceuticals price target raised to $672 from $605 at BofA

TIPRANKS
·
Aug 11

Vertex Stock (VRTX) Soars 7% as Rival Sionna (SION) Crashes 92% on Failed Drug Trial

TIPRANKS
·
Aug 10

Early notable gainers among liquid option names on August 10th

TIPRANKS
·
Aug 10

Vertex Pharmaceuticals Inc Stock (VRTX) Opened Up by 9.76% on Aug 10: What Investors Need To Know

TradingKey
·
Aug 10

Vertex Pharmaceuticals Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 08

Vertex Pharmaceuticals Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 06

Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX) and Q32 Bio (QTTB)

TIPRANKS
·
Aug 06

Rothschild & Co Redburn Adjusts Vertex Pharmaceuticals Price Target to $580 From $570

MT Newswires Live
·
Aug 05

Vertex Pharmaceuticals price target raised to $617 from $615 at Barclays

TIPRANKS
·
Aug 05

Vertex Inc. Earnings Call Shows Profitable Growth

TIPRANKS
·
Aug 05

Vertex Pharmaceuticals Seen Well Positioned Ahead of Pipeline Catalysts, UBS Says

MT Newswires Live
·
Aug 05

Vertex Pharmaceuticals' Solid Q2, Raised Outlook Underscore Core Business Strength, RBC Says

MT Newswires Live
·
Aug 05

Evercore ISI Keeps Their Buy Rating on Vertex Pharmaceuticals (VRTX)

TIPRANKS
·
Aug 04

Analysts Offer Insights on Healthcare Companies: AMN Healthcare Services (AMN), Fresenius Medical Care (FMS) and Vertex Pharmaceuticals (VRTX)

TIPRANKS
·
Aug 04

Vertex Pharmaceuticals: Solid Q2 Beat and Raised 2026 Guidance, But Early-Stage Diversification and CRNX Integration Keep Rating at Hold

TIPRANKS
·
Aug 04

Vertex Upgraded to Buy as Strong Q2, Raised 2026 Guidance and Higher $605 Price Target Signal Durable, Diversified Growth

TIPRANKS
·
Aug 04

Vertex: Buy Rating Reaffirmed Amid Near-Term Demand Headwinds and Strategic Transformation, Price Target Maintained at $20

TIPRANKS
·
Aug 04